2.16
price down icon5.26%   -0.12
after-market After Hours: 2.21 0.05 +2.31%
loading

Black Diamond Therapeutics Inc Stock (BDTX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.92%
20.25
20.86 24.01 20.03 21.56
Operating Income/Loss
2.92%
-20.25
-20.86 -24.01 -20.03 -21.56
Nonoperating Income/Loss
39.67%
2.021
1.447 1.005 0.88 0.686
Income/Loss From Continuing Operations Before Tax
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Income/Loss From Continuing Operations After Tax
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Net Income/Loss
6.10%
-18.23
-19.41 -23.01 -19.15 -20.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,902%
51.81
2.5873 50.94 36.52 36.48
Diluted Average Shares
1,902%
51.81
2.5873 50.94 36.52 36.48
Basic Earnings Per Share
2.94%
-0.35
-0.34 -0.45 -0.52 -0.57
Diluted Earnings Per Share
2.94%
-0.35
-0.34 -0.45 -0.52 -0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Cap:     |  Volume (24h):